Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma

References

• Albige, L., Choueiri, T., Escudier, B., Galsky, M., George, D., Hofmann, F., Lam, T., Motzer, R., Mulders, P., Porta, C., Powles, T., Sternberg, C., & Bex, A. (2015). A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. European Urology, 67(1), 100–110. https://doi.org/10.1016/j.eururo.2014.04.006
   PubMedGoogle Scholar
• Allory, Y., Culine, S., & de la Taille, A. (2011). Kidney cancer pathology in the new context of targeted therapy. Pathobiology, 78(2), 90–98. https://doi.org/10.1159/000315543
   PubMedGoogle Scholar
• Bader, G. D., & Hogue, C. W. (2003). An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics, 4(1), 2. https://doi.org/10.1186/1471-2105-4-2
   PubMed Web of Science ®Google Scholar
• Bai, X., Yi, M., Dong, B., Zheng, X., & Wu, K. (2020). The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Experimental Hematology & Oncology, 9(1), 1–15. https://doi.org/10.1186/s40164-020-00181-3
   PubMedGoogle Scholar
• Brugarolas, J. (2014). Molecular genetics of clear-cell renal cell carcinoma. Journal of Clinical Oncology, 32(18), 1968–1976. https://doi.org/10.1200/jco.2012.45.2003
   PubMed Web of Science ®Google Scholar
• Burrows, A. E., Smogorzewska, A., & Elledge, S. J. (2010). Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proceedings of the National Academy of Sciences, 107(32), 14280–14285. https://doi.org/10.1073/pnas.1009559107
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43–49. https://doi.org/10.1038/nature12222
   PubMed Web of Science ®Google Scholar
• Carril-Ajuria, L., Santos, M., Roldán-Romero, J. M., Rodriguez-Antona, C., & de Velasco, G. (2019). Prognostic and predictive value of PBRM1 in clear cell renal cell carcinoma. Cancers(basel), 12(1), 16. https://doi.org/10.3390/cancers12010016
   PubMed Web of Science ®Google Scholar
• Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., & Schultz, N. (2012). The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401–404. https://doi.org/10.1158/2159-8290.cd-12-0095
   PubMed Web of Science ®Google Scholar
• Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biology, 4(9). https://doi.org/10.1186/gb-2003-4-5-p3
   Google Scholar
• DiFranco, G., Palmeri, M., Sbrana, A., Gianardi, D., Furbetta, N., Guadagni, S., Bianchini, M., Stefanini, G., Adamo, G., Pollina, L. E., Galli, L., DiCandio, G., & Morelli, L. (2020). Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence. Surgical Oncology, 35, 106–113. https://doi.org/10.1016/j.suronc.2020.08.002
   PubMedGoogle Scholar
• Gu, X., Enane, F., Tohme, R., Schuerger, C., Radivoyevitch, T., Parker, Y., Zuberi, E., Przychodzen, B., Jha, B. K., Lindner, D., Rini, B., & Saunthararajah, Y. (2021). PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation. Cell Reports, 36(12), 109747. https://doi.org/10.1016/j.celrep.2021.109747
   PubMedGoogle Scholar
• Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell, 2(4), 289–300. https://doi.org/10.1016/s1535-6108(02)00153-8
   PubMed Web of Science ®Google Scholar
• Hwang, C., & Heath, E. I. (2014). The judgment of Paris: Treatment dilemmas in advanced renal cell carcinoma. Journal of Clinical Oncology, 32(8), 729–734. https://doi.org/10.1200/jco.2013.53.6029
   PubMedGoogle Scholar
• Linehan, W. M. (2012). Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics. Genome Research, 22(11), 2089–2100. https://doi.org/10.1101/gr.131110.111
   PubMedGoogle Scholar
• McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012). Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Research, 40(10), 4288–4297. https://doi.org/10.1093/nar/gks042
   PubMed Web of Science ®Google Scholar
• Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016). The 2016 WHO classification of tumours of the urinary system and male genital organs—Part A: Renal, penile, and testicular tumours. European Urology, 70(1), 93–105. https://doi.org/10.1016/j.eururo.2016.02.029
   PubMed Web of Science ®Google Scholar
• Nargund, A. M., Pham, C. G., Dong, Y., Wang, P. I., Osmangeyoglu, H. U., Xie, Y., Aras, O., Han, S., Oyama, T., Takeda, S., Ray, C. E., Dong, Z., Berge, M., Hakimi, A. A., Monette, S., Lekaye, C. L., Koutcher, J. A., Leslie, C. S., Creighton, C. J. … Hsieh, J. J. (2017). The SWI/SNF protein PBRM1 restrains VHL-Loss-driven clear cell renal cell carcinoma. Cell Reports, 18(12), 2893–2906. https://doi.org/10.1016/j.celrep.2017.02.074
   PubMed Web of Science ®Google Scholar
• Niu, H., Li, F., Wang, Q., Ye, Z., Chen, Q., & Lin, Y. (2018). High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma. PeerJ [Internet], 6, e5050. https://doi.org/10.7717/peerj.5050
   PubMed Web of Science ®Google Scholar
• Pawłowski, R., Mühl, S. M., Sulser, T., Krek, W., Moch, H., & Schraml, P. (2012). Loss of PBRM1 expression is associated with renal cell carcinoma progression. International Journal of Cancer, 132(2), E11–17. https://doi.org/10.1002/ijc.27822
   PubMedGoogle Scholar
• Robert, C., Thomas, L., Bondarenko, I., O’Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J. -F., Testori, A., Grob, J. -J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W. H., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R. … Wolchok, J. D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. The New England Journal of Medicine, 364(26), 2517–2526. https://doi.org/10.1056/nejmoa1104621
   PubMed Web of Science ®Google Scholar
• Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2009). edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics [Internet], 26(1), 139–140. https://doi.org/10.1093/bioinformatics/btp616
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., Kuhn, M., Bork, P., Jensen, L. J., & von Mering, C. (2015). STRING v10: Protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Research, 43(D1), D447–52. https://doi.org/10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45(W1), W98–102. https://doi.org/10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Thevenod, F., & Chakraborty, P. K. (2010). The role of Wnt/Beta-catenin signaling in renal carcinogenesis: Lessons from cadmium toxicity studies. Current Molecular Medicine, 10(4), 387–404. https://doi.org/10.2174/156652410791316986
   PubMed Web of Science ®Google Scholar
• Wu, X., Daniels, G., Lee, P., & Monaco, M. E. (2014). Lipid metabolism in prostate cancer. American Journal of Clinical and Experimental Urology, 2(2), 111–120. https://pubmed.ncbi.nlm.nih.gov/25374912
   PubMedGoogle Scholar
• Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., Ramaswamy, S., Futreal, P. A., Haber, D. A., Stratton, M. R., Benes, C., McDermott, U., & Garnett, M. J. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Research, 41(D1), D955–61. https://doi.org/10.1093/nar/gks1111
   PubMed Web of Science ®Google Scholar
• Zemp, F., Rajwani, J., & Mahoney, D. J. (2018). Rhabdoviruses as vaccine platforms for infectious disease and cancer. Biotechnology & Genetic Engineering Reviews, 34(1), 122–138. https://doi.org/10.1080/02648725.2018.1474320
   PubMed Web of Science ®Google Scholar